In Vitro Diagnostic Examination and Prognosis Surveillance by Hierarchical Heterojunction-Assisted Metabolic Analysis
High-throughput metabolic analysis based on laser desorption/ionization mass spectrometry exhibits broad prospects in the field of large-scale precise medicine, for which the assisted ionization ability of the matrix becomes a determining step. In this work, the gold-decorated hierarchical metal oxide heterojunctions (dubbed Au/HMOHs) are proposed as a matrix for extracting urine metabolic fingerprints (UMFs) of primary nephrotic syndrome (PNS). The hierarchical heterojunctions are simply derived from metal-organic framework (MOF)-on-MOF hybrids, and the native built-in electric field from heterojunctions plus the extra Au decoration provides remarkable ionization efficiency, attaining high-quality UMFs. These UMFs are employed to realize precise diagnosis, subtype classification, and effective prognosis evaluation of PNS by appropriate machine learning, all with 100% accurate ratios. Moreover, a high-confidence marker panel for PNS diagnosis is constructed. Interestingly, all panel metabolite markers present obviously uniform downregulation in PNS compared to healthy controls, shedding light on mechanism exploration and pathway analysis. This work drives the application of metabolomics toward precision medicine.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:94 |
---|---|
Enthalten in: |
Analytical chemistry - 94(2022), 29 vom: 26. Juli, Seite 10497-10505 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Shi, Fangying [VerfasserIn] |
---|
Links: |
---|
Themen: |
7440-57-5 |
---|
Anmerkungen: |
Date Completed 27.07.2022 Date Revised 03.08.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1021/acs.analchem.2c01784 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM343596660 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM343596660 | ||
003 | DE-627 | ||
005 | 20231226020823.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1021/acs.analchem.2c01784 |2 doi | |
028 | 5 | 2 | |a pubmed24n1145.xml |
035 | |a (DE-627)NLM343596660 | ||
035 | |a (NLM)35839420 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Shi, Fangying |e verfasserin |4 aut | |
245 | 1 | 0 | |a In Vitro Diagnostic Examination and Prognosis Surveillance by Hierarchical Heterojunction-Assisted Metabolic Analysis |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.07.2022 | ||
500 | |a Date Revised 03.08.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a High-throughput metabolic analysis based on laser desorption/ionization mass spectrometry exhibits broad prospects in the field of large-scale precise medicine, for which the assisted ionization ability of the matrix becomes a determining step. In this work, the gold-decorated hierarchical metal oxide heterojunctions (dubbed Au/HMOHs) are proposed as a matrix for extracting urine metabolic fingerprints (UMFs) of primary nephrotic syndrome (PNS). The hierarchical heterojunctions are simply derived from metal-organic framework (MOF)-on-MOF hybrids, and the native built-in electric field from heterojunctions plus the extra Au decoration provides remarkable ionization efficiency, attaining high-quality UMFs. These UMFs are employed to realize precise diagnosis, subtype classification, and effective prognosis evaluation of PNS by appropriate machine learning, all with 100% accurate ratios. Moreover, a high-confidence marker panel for PNS diagnosis is constructed. Interestingly, all panel metabolite markers present obviously uniform downregulation in PNS compared to healthy controls, shedding light on mechanism exploration and pathway analysis. This work drives the application of metabolomics toward precision medicine | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Biomarkers |2 NLM | |
650 | 7 | |a Metal-Organic Frameworks |2 NLM | |
650 | 7 | |a Gold |2 NLM | |
650 | 7 | |a 7440-57-5 |2 NLM | |
700 | 1 | |a Zhou, Jie |e verfasserin |4 aut | |
700 | 1 | |a Wu, Yonglei |e verfasserin |4 aut | |
700 | 1 | |a Hu, Xufang |e verfasserin |4 aut | |
700 | 1 | |a Xie, Qionghong |e verfasserin |4 aut | |
700 | 1 | |a Deng, Chunhui |e verfasserin |4 aut | |
700 | 1 | |a Sun, Nianrong |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Analytical chemistry |d 1965 |g 94(2022), 29 vom: 26. Juli, Seite 10497-10505 |w (DE-627)NLM000025771 |x 1520-6882 |7 nnns |
773 | 1 | 8 | |g volume:94 |g year:2022 |g number:29 |g day:26 |g month:07 |g pages:10497-10505 |
856 | 4 | 0 | |u http://dx.doi.org/10.1021/acs.analchem.2c01784 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 94 |j 2022 |e 29 |b 26 |c 07 |h 10497-10505 |